| Dr Amber Marie Coon, MD | |
|
4403 6th St, Lubbock, TX 79416-4733 | |
| (806) 791-1122 | |
| (806) 791-2252 |
| Full Name | Dr Amber Marie Coon |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 14 Years |
| Location | 4403 6th St, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164747960 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | Q0236 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Medical Center | Lubbock, TX | Hospital |
| Covenant Childrens Hospital | Lubbock, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Umc Physicians | 9830003631 | 114 |
News Archive
The ALS Association and The Tow Foundation are pleased to announce their continuing support of the New York Genome Center's Center for Genomics of Neurodegenerative Disease, in recognition of the substantial genomic research being carried out by NYGC scientists.
JenaValve™ Technology, Inc., a medical device company specialized in developing transcatheter valve replacement products, announced today the start of its multicenter CE-mark study. The first two implantations of its transapical TAVI system were performed by Dr. med. Hendrik Treede at the Universitäres Herzzentrum Hamburg.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the expansion of their research, development and license agreement for the discovery of novel kinase inhibitors in the field of oncology. This expanded agreement establishes a third therapeutic target, with an option for a fourth, in the field of oncology, and it includes a two-year extension based on the application of the proprietary ArQule Kinase Inhibitor Platform (AKIP™) technology.
Artemisinin-based combination therapies (ACTs) are the currently recommended drugs for treating malaria. However, they are expensive, which limits their affordability. This means that people with malaria are likely to buy cheaper, less effective antimalarials such as chloroquine and sulphadoxine-pyrimethamine; or to simply buy painkillers and antipyretics.
Blood clots continue to wreak havoc for patients with severe COVID-19 infection, and a new study explains what may spark them in up to half of patients.
› Verified 1 days ago
| Entity Name | Susan R Devine |
|---|---|
| Entity Type | Practitioner - Obstetrics/gynecology |
| Entity Identifiers | NPI Number: 1518986827 PECOS PAC ID: 7911021837 Enrollment ID: I20100830000856 |
News Archive
The ALS Association and The Tow Foundation are pleased to announce their continuing support of the New York Genome Center's Center for Genomics of Neurodegenerative Disease, in recognition of the substantial genomic research being carried out by NYGC scientists.
JenaValve™ Technology, Inc., a medical device company specialized in developing transcatheter valve replacement products, announced today the start of its multicenter CE-mark study. The first two implantations of its transapical TAVI system were performed by Dr. med. Hendrik Treede at the Universitäres Herzzentrum Hamburg.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the expansion of their research, development and license agreement for the discovery of novel kinase inhibitors in the field of oncology. This expanded agreement establishes a third therapeutic target, with an option for a fourth, in the field of oncology, and it includes a two-year extension based on the application of the proprietary ArQule Kinase Inhibitor Platform (AKIP™) technology.
Artemisinin-based combination therapies (ACTs) are the currently recommended drugs for treating malaria. However, they are expensive, which limits their affordability. This means that people with malaria are likely to buy cheaper, less effective antimalarials such as chloroquine and sulphadoxine-pyrimethamine; or to simply buy painkillers and antipyretics.
Blood clots continue to wreak havoc for patients with severe COVID-19 infection, and a new study explains what may spark them in up to half of patients.
› Verified 1 days ago
| Entity Name | Umc Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669418547 PECOS PAC ID: 9830003631 Enrollment ID: O20040406001716 |
News Archive
The ALS Association and The Tow Foundation are pleased to announce their continuing support of the New York Genome Center's Center for Genomics of Neurodegenerative Disease, in recognition of the substantial genomic research being carried out by NYGC scientists.
JenaValve™ Technology, Inc., a medical device company specialized in developing transcatheter valve replacement products, announced today the start of its multicenter CE-mark study. The first two implantations of its transapical TAVI system were performed by Dr. med. Hendrik Treede at the Universitäres Herzzentrum Hamburg.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the expansion of their research, development and license agreement for the discovery of novel kinase inhibitors in the field of oncology. This expanded agreement establishes a third therapeutic target, with an option for a fourth, in the field of oncology, and it includes a two-year extension based on the application of the proprietary ArQule Kinase Inhibitor Platform (AKIP™) technology.
Artemisinin-based combination therapies (ACTs) are the currently recommended drugs for treating malaria. However, they are expensive, which limits their affordability. This means that people with malaria are likely to buy cheaper, less effective antimalarials such as chloroquine and sulphadoxine-pyrimethamine; or to simply buy painkillers and antipyretics.
Blood clots continue to wreak havoc for patients with severe COVID-19 infection, and a new study explains what may spark them in up to half of patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amber Marie Coon, MD 5219 City Bank Pkwy Ste 35, Lubbock, TX 79407-3545 Ph: (806) 761-0333 | Dr Amber Marie Coon, MD 4403 6th St, Lubbock, TX 79416-4733 Ph: (806) 791-1122 |
News Archive
The ALS Association and The Tow Foundation are pleased to announce their continuing support of the New York Genome Center's Center for Genomics of Neurodegenerative Disease, in recognition of the substantial genomic research being carried out by NYGC scientists.
JenaValve™ Technology, Inc., a medical device company specialized in developing transcatheter valve replacement products, announced today the start of its multicenter CE-mark study. The first two implantations of its transapical TAVI system were performed by Dr. med. Hendrik Treede at the Universitäres Herzzentrum Hamburg.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the expansion of their research, development and license agreement for the discovery of novel kinase inhibitors in the field of oncology. This expanded agreement establishes a third therapeutic target, with an option for a fourth, in the field of oncology, and it includes a two-year extension based on the application of the proprietary ArQule Kinase Inhibitor Platform (AKIP™) technology.
Artemisinin-based combination therapies (ACTs) are the currently recommended drugs for treating malaria. However, they are expensive, which limits their affordability. This means that people with malaria are likely to buy cheaper, less effective antimalarials such as chloroquine and sulphadoxine-pyrimethamine; or to simply buy painkillers and antipyretics.
Blood clots continue to wreak havoc for patients with severe COVID-19 infection, and a new study explains what may spark them in up to half of patients.
› Verified 1 days ago
Marcel Lamothe, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4102 24th St Ste 505, Lubbock, TX 79410 Phone: 806-725-7275 Fax: 806-723-7039 | |
Esther Oluwakemi Ogunjimi, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3601 4th Street Ms 8340, Dept Ob/gyn, Lubbock, TX 79430 Phone: 209-476-2080 | |
Dr. Brent Boye Nall, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4515 Marsha Sharp Fwy, Lubbock, TX 79407 Phone: 806-744-7223 Fax: 806-740-3325 | |
Joseph Kimberly Killeen, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4102 24 St, Suite 502, Lubbock, TX 79410 Phone: 806-725-6745 Fax: 806-723-6716 | |
Kathleen Kay Sears, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3709 22nd Pl Unit B, Lubbock, TX 79410 Phone: 806-797-2618 Fax: 806-791-3122 | |
Bill Atkinson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4102 24th St, Ste 300, Lubbock, TX 79410 Phone: 806-725-5497 Fax: 806-723-6299 | |
Rebecca Birdwell, NP-C Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3601 4th St, Lubbock, TX 79430 Phone: 325-220-1371 |